Strontium Chloride
PreclinicalSmall molecule
Strontium Chloride is one of 5 small molecule programs targeting Oocyte. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Oocyte
#DrugCompanyPhaseTrials
1Decapeptyl
SSheba Medical Center
Preclinical
Ovitrelle
Merck & Co.Preclinical
Dual Trigger
WWeill Medical College of Cornell University
Preclinical
Strontium Chloride
IIbn Sina Hospital
Preclinical
In Vitro Maturation
NNorthwell Health
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Strontium Chloride. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- IIbn Sina Hospital